CHUV, Lausanne

Ongoing therapeutic and lab-based clinical studies at the Service de Dermatologie, LAUSANNE

Therapeutic trials :
1) AMAGINE-1, Protocole 20120102 “A Phase 3 Study to Evaluate the Efficacy, Safety, and Effect of Withdrawal and Retreatment With Brodalumab in Subjects With Moderate to Severe Plaque Psoriasis:”
Contact: Prof. Gilliet

2) NOVARTIS: “A Phase 3 Study to Evaluate the Efficacy, Safety, and Effect of Sekukinumab in Subjects With Moderate to Severe Plaque Psoriasis”
Contact: Dr. Conrad

3) ABBOTT M11-810: “A phase 3 study of the safety and efficacy of Adalimumab in subjects with moderate to severe Hidradenitis Suppurativa”
Contact: Dr. Feldmeyer

4) Efficacy of 5% imiquimod on cicatrisation of chronic leg ulcers
Contact: Dr. Perrier

Lab-based Clinical studies
1) ATOPIC DERMATITIS ONSET STUDY
Contact: Dr Christen, PD

2) ROSACEA: epidemiological, clinical and molecular characterisation
Contact: Dr Czernielewski

3) LUPUS ERYTHEMATOSUS: NETs and anti-NETs antibodies as disease markers
Contact: Dr Feldmeyer/Prof. Gilliet

4) BIOLOGICS: effects on antiviral memory T cell responses Contact: Dr Flatz

5) METASTATIC MELANOMA: circulating c-kit+ cells as prognostic marker. Contact: Dr Kuonen

6) PARADOXIC PSORIASIS: pathogenic mechanism Contact: Dr Conrad, PD

7) SYPHILIS: PCR Contact: Dr Feldmeyer

8) PRIMARY MELANOMA AND SQUAMOUS CELL CARCINOMA: genetic and molecular analysis Contact: Dr Perrier

9) ONYCHOMYCOSIS: PCR as diagnostic tool Contact: Prof. Monod